全文获取类型
收费全文 | 242篇 |
免费 | 31篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 15篇 |
妇产科学 | 2篇 |
基础医学 | 40篇 |
临床医学 | 11篇 |
内科学 | 107篇 |
皮肤病学 | 4篇 |
神经病学 | 13篇 |
外科学 | 54篇 |
综合类 | 6篇 |
预防医学 | 12篇 |
药学 | 4篇 |
中国医学 | 1篇 |
肿瘤学 | 3篇 |
出版年
2023年 | 1篇 |
2022年 | 4篇 |
2021年 | 12篇 |
2020年 | 7篇 |
2019年 | 6篇 |
2018年 | 13篇 |
2017年 | 6篇 |
2016年 | 17篇 |
2015年 | 11篇 |
2014年 | 10篇 |
2013年 | 12篇 |
2012年 | 21篇 |
2011年 | 31篇 |
2010年 | 20篇 |
2009年 | 10篇 |
2008年 | 17篇 |
2007年 | 6篇 |
2006年 | 18篇 |
2005年 | 6篇 |
2004年 | 8篇 |
2003年 | 10篇 |
2002年 | 4篇 |
2001年 | 2篇 |
2000年 | 1篇 |
1999年 | 1篇 |
1997年 | 1篇 |
1996年 | 1篇 |
1995年 | 2篇 |
1994年 | 1篇 |
1993年 | 1篇 |
1992年 | 2篇 |
1991年 | 2篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1987年 | 1篇 |
1986年 | 1篇 |
1980年 | 2篇 |
1940年 | 1篇 |
1936年 | 1篇 |
1933年 | 1篇 |
排序方式: 共有273条查询结果,搜索用时 14 毫秒
101.
102.
Ujjwal Neogi Sreenivasa B Prarthana George D'Souza Ayesha DeCosta Vijesh S Kuttiatt Udaykumar Ranga Anita Shet 《AIDS research and therapy》2010,7(1):24
Background
Understanding co-receptor tropism of HIV-1 strains circulating in India will provide key analytical leverage for assessing the potential usefulness of newer antiretroviral drugs such as chemokine co-receptor antagonists among Indian HIV-infected populations. The objective of this study was to determine using in silico methods, HIV-1 tropism among a large number of Indian isolates both from primary clinical isolates as well as from database-derived sequences. 相似文献103.
104.
Daniel K. White Yuqing Zhang David T. Felson Jingbo Niu Julie J. Keysor Michael C. Nevitt Cora E. Lewis James C. Torner Tuhina Neogi 《Arthritis care & research》2010,62(7):938-943
Objective
Although knee pain severity is thought to greatly impact function, the additional contribution of pain in 1 versus 2 knees is not known. We examined the relationship between unilateral versus bilateral pain with low physical functioning at baseline and 30 months while accounting for knee pain severity.Methods
The Multicenter Osteoarthritis Study is a cohort study of people who have or are at high risk for knee osteoarthritis. We defined low physical function as Western Ontario and McMaster Universities Osteoarthritis Index physical functioning scores ≥28 of 68, consistent with poor functional outcome. Incidence and improvement from low physical function were defined as scores that declined below and improved above this threshold at 30 months. We examined the association between pain in 1 or 2 knees with low physical function with risk ratios (RRs) adjusting for known confounders.Results
Of the 2,069 subjects (mean ± SD age 63 ± 8 years, mean ± SD body mass index 31 ± 6 kg/m2, 63% women), the prevalence of low physical functioning was 50% lower among persons with unilateral pain compared with those with bilateral pain (adjusted prevalence ratio 0.5 [95% confidence interval (95% CI) 0.3–0.7]). Of those without low physical functioning at baseline, the risk of incidence at 30 months was 30% less for unilateral compared with bilateral pain (adjusted RR 0.7 [95% CI 0.5–1.0]). Of those with low physical functioning at baseline, improvement was 1.7 times more likely for those with unilateral compared with bilateral pain (adjusted RR 1.7 [95% CI 1.3–2.2]).Conclusion
The presence of pain in 1 versus 2 knees provides important information regarding present and future physical functioning. 相似文献105.
Neogi U Sahoo PN Kumar R De Costa A Shet A 《AIDS research and human retroviruses》2011,27(11):1249-1253
Significant subtype-specific differences were observed in the protease (PR) region of the HIV-1 pol gene. Most of the previous studies were restricted to subtype B, although subtype C accounts for more than 50% of HIV infections worldwide. In this study we characterized PR sequences from primary clinical isolates from protease inhibitor (PI)-naive patients in South India (n=39) as well as database-derived HIV-1 subtype C sequences from India (n=542) and globally (n=2970). All the study sequences were identified as subtype C, which is predominant in India. Drug resistance genotyping analysis identified 2.6% (1/39) prevalence of major PI resistance (I54T) and 7.7% (3/39) of minor PI resistance (L10I, T74S, and A71T). Selection of T12S, I15V, L19I, M36I, R41K, H69K, L89M, and I93L was observed both in global and Indian subtype C while the L63P mutation was selected in Indian PR sequences. Three different codon-based maximum likelihood methods agreed on four sites (12, 19, 36, and 82) under positive selection in Indian sequences. 相似文献
106.
Zhang Y Woods R Chaisson CE Neogi T Niu J McAlindon TE Hunter D 《The American journal of medicine》2006,119(9):800-800.e18
Background
Alcohol consumption has long been considered a trigger for recurrent gout attacks; however, this hypothesis has not been formally tested.Methods
We conducted an Internet-based case-crossover study to assess several putative risk factors, including alcohol consumption, thought to trigger recurrent gout attacks. Subjects who had an attack within the past year were recruited online and asked to provide access to medical records pertaining to their gout. Data were obtained on the amount and type of alcoholic beverage consumed on each day over the 2-day period before a gout attack and on each day over a 2-day period during the intercritical period. We examined the amount and type of alcohol consumption and the risk of recurrent gout attacks using a conditional logistic regression adjusting for diuretic use and purine intake.Results
A total of 197 subjects were recruited online over a 10-month period. Of those, 179 (91%) fulfilled the American College of Rheumatology Criteria for gout. Compared with no alcohol consumption, odds ratios for recurrent gout attacks were 1.1, 0.9, 2.0, and 2.5 for 1 to 2, 3 to 4, 5 to 6, and 7 or more drinks consumed over the 2-day period, respectively (P<.005). A dose-response relationship of risk of gout attacks was more evident for alcohol consumed over the last 24 hours. An increased risk of recurrent gout attacks was found for each type of beverage consumed.Conclusion
Alcohol consumption triggers recurrent gout attacks. This effect was likely to occur within 24 hours after its consumption. 相似文献107.
Development of the American College of Rheumatology Electronic Clinical Quality Measures for Gout 下载免费PDF全文
John D. FitzGerald Ted R. Mikuls Tuhina Neogi Jasvinder A. Singh Mark Robbins Puja P. Khanna Amy S. Turner Rachel Myslinski Lisa G. Suter 《Arthritis care & research》2018,70(5):659-671
Objective
Electronic clinical quality measures (eCQMs) are increasingly used by health registries and third parties to evaluate and improve the quality of health care. To complete these eCQMs, data are extracted from electronic health records (EHRs). The treatment of gout has been an area identified with gaps in quality of care. On behalf of the American College of Rheumatology (ACR), we sought to develop and test eCQMs to evaluate gout care.Methods
Drawing from the 2012 ACR gout guidelines, a working group developed candidate gout process measures that were evaluated by an interdisciplinary panel of health care stakeholders, the ACR Quality Measures Subcommittee (QMS), and ultimately the ACR Board of Directors for formal validity testing. For each of the selected gout eCQMs, 3 clinical sites using different EHR systems tested the scientific feasibility and validity of the measures. Measures appropriate for accountability were presented for national endorsement.Results
Of the 10 proposed eCQMs, 4 were endorsed by the ACR QMS, 3 were incorporated into the ACR's Rheumatology Informatics System for Effectiveness (RISE) Registry, and 2 were endorsed by the National Quality Forum. The 3 eCQMs incorporated into RISE (evaluating indications for urate‐lowering therapy [ULT]), monitoring serum urate, and treat‐to‐target outcome) demonstrated high validity and reliability. Proportions of patients passing these 3 eCQMs in RISE and at the 3 clinical testing sites ranged between 32% and 58%, indicating significant room for improvement in care.Conclusion
Three eCQMs have been validated and implemented into RISE. Two of these measures (evaluating indications for ULT and monitoring serum urate) are available for use in federal quality reporting programs. Performance on these measures suggests there is significant room for improvement in the management of gout.108.
Retained surgical sponge or glossypiboma is a relatively common occurrence; however, surgeons may not report these events for fear of litigation and adverse publicity. We report postoperative complications in three cases due to retained surgical sponges. The first case, a 26-year-old woman, presented with gastric outlet obstruction due to the sponge obstructing the pyloric canal three weeks following cholecystectomy, which was completely relieved following endoscopical removal of the sponge. The second case, a 32-year-old woman, presented with repeated attacks of intestinal obstruction following cholecystectomy and tubal ligation and was treated with surgical removal of the sponge. The third patient, a 40-year-old woman, presented with features of colonic obstruction following hysterectomy. Colonoscopy revealed a partial migration of the sponge through the colonic wall and on laparotomy, she was found to have multiple internal fistulae between the small and large intestines, all occurring around the inflammation caused by the retained sponge. 相似文献
109.
110.
Rotavirus vaccines have been developed to prevent deaths resulting from severe diarrhea of rotavirus origin. The use of vaccines
as an intervention at scale to prevent and control the burden of rotavirus diarrhea is supported by the argument that prevailing
public health measures such as hygiene and sanitation, breast feeding and use of ORS have failed to prevent severe dehydration
resulting from diarrhea. The article reviews the existing evidence on the rationale of using rotavirus vaccine as against
the feasibility of scaling it up in developing countries like India. The vaccines currently available may not cover the strains
circulating in Indian population. The diversity of Rotavirus infection in the country is tremendous and since the safety,
immunogenicity and efficacy data has not been collected for India, there is first a need to conduct studies to measure the
extent of protection and cross-protection provided by the available vaccines for local strains, before venturing into Rotavirus
vaccination program. The potential benefits of immunization have to be first vetted against the risks involved by the policymakers
and other stakeholders. 相似文献